Loading

Clinical Trials

In a Russian clinical trial Carnosine eye-drops were used to treat nearly 100 patients aged 60 and above. All the patients had senile cataract in various degrees of maturity – from 2 – 21 years. The patients instilled 1 or 2 drops into each eye 3 or 4 times a day, for a period of 3 to 6 months. The results showed that there was a 100% improvement on senile cataract with no side effects.

A second clinical study was designed to document and quantify the changes in lens clarity over a 6 to 24 month period. The average age of the 49 participants was 65 and all suffered from senile cataract of a minimal to an advanced opacification. The patients received either a 1% solution of N-acetylcarnosine eye-drops or a placebo as 2-drops twice a day into each eye. The results at 6 months were impressive; 88.9% of all eyes treated with N-acetylcarnosine had an improvement of glare sensitivity. Furthermore, 90% of the eyes treated with N-acetylcarnosine showed an improvement in visual acuity. In contrast, there was little change in the eye quality of the placebo group at 6 months and the placebo group also experienced a gradual deterioration at 12 to 24 months. Importantly, this study also showed that at 24-months the CAN-C CONTAINING NAC treated group, (who already had significant improvement to the quality of their eyesight), sustained these results with continued use of the CAN-C CONTAINING NAC eye-drops, once again, no significant side effects were noted in any cases throughout the 2-year period.

Another study evaluated patients between 48-60, who had various degrees of eyesight impairment but who did not have the symptoms of cataract. After a course of treatment ranging from 2 to 6 months the conclusion was that the eye-drops alleviated eye tiredness and continued to improve eyesight (i.e. there was more clear vision). This is an indicator that the eye-drops also have qualities for the prevention of eye degeneration. Specifically in canines and rabbits the administration of CAN-C CONTAINING NAC eye drops produced remarkably fast results in the improvement of clarity, glare sensitivity and overall vision for the animals involved. Furthermore, no serious side effects were noted and the beneficial affects were sustainable.

For further clinical trials and studies please click here